AI-ENDO assistance for endoscopic submucosal dissection (ESD)
Official title: Clinical Utility and Validation of Novel AI-ENDO System in Endoscopic Submucosal Dissection
Run by Chinese University of Hong Kong · NCT07392268 · Data updated 2026-11-12
This pilot will try using the AI-ENDO system to help doctors perform ESD in adults with superficial esophageal, stomach, or colorectal lesions.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Chinese University of Hong Kong Academic / other |
| Locations | 1 site (Hong Kong) |
| Status | Recruiting |
| Started | May 1, 2025 |
| Main results expected | June 30, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | February 6, 2026 |
| Trial ID | NCT07392268 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–85 scheduled for conventional ESD for superficial esophageal, gastric, or colorectal lesions who can provide informed consent are the intended participants.
✕Probably not a fit
Patients with lesions unsuitable for ESD, those requiring alternative or more advanced cancer treatment, or people who decline participation are unlikely to benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The trial tests the AI-ENDO software during ESD procedures on adults with superficial lesions of the esophagus, stomach, or colon. In the first phase the system will run in the background for 30 conventional ESD cases to analyse real-time video without affecting the endoscopist and to provide a control dataset. A subsequent phase will use AI-ENDO to provide active, real-time support to endoscopists and compare technical and safety outcomes versus the background cases. All procedures are performed at the Endoscopy Centre of Prince of Wales Hospital under the Chinese University of Hong Kong.
Why it matters
Potential benefit: If successful, AI-ENDO could improve completeness and safety of ESD by offering real-time guidance that may reduce procedure time and complications.
How similar studies have gone: AI tools have shown promise for lesion detection and characterization in endoscopy, but AI-assisted guidance specifically for ESD is still early and has limited clinical validation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient with superficial esophageal, gastric or colorectal lesions, scheduled for endoscopic submucosal dissection (ESD). * Age between 18 and 85. Exclusion Criteria: * Patient who refused to participate. * Other cases deemed by the examining physician as unsuitable for safe treatment.
Where it's running
-
Department of Surgery, Faculty of Medicine, the Chinese University of Hong Kong
Hong Kong, Hong Kong Recruiting
Study contacts
- Study coordinator: Hon Chi Yip
- Email: hcyip@surgery.cuhk.edu.hk
- Phone: +852 3505 2956
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Postpartum exercise to improve heart and metabolic health in women at high risk for preeclampsia
This pilot study tests whether a 12‑week postpartum exercise program can improve heart health and metabolic markers in women who were at high risk for preeclampsia.
-
Ultrasound-guided microwave ablation for benign thyroid nodules
This study tests whether using ultrasound-guided microwave ablation to shrink benign thyroid nodules under local anesthesia is safe and effective, compared with traditional surgery.
-
Romiplostim added to standard ESA therapy in adults on hemodialysis with ESA-resistant anemia
This phase 2 study tests whether adding romiplostim to ongoing ESA treatment is safe and tolerable for adults on dialysis whose anemia does not respond well to ESAs.
-
Metomidate PET-CT vs Usual Care for Primary Aldosteronism
This study tests whether [11C] metomidate PET-CT can help orient treatment for people with primary aldosteronism compared with the usual adrenal venous sampling approach.
-
VR-based sensory stimulation to prevent delirium in ICU patients
This trial tests whether immersive virtual reality sensory stimulation can delay or reduce delirium in adult ICU patients compared with a non-immersive, tablet-based sensory experience.
-
Comprehensive clinical rule to diagnose acute heart failure in the emergency department
A prospective study tests a combined clinical rule using patient data, a point-of-care NT-proBNP test, an 8-point lung ultrasound, and bedside echo to quickly diagnose acute heart failure in adults with new or worsening symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.